COVID vaccine‐induced reaction around molluscum contagiosum with secondary partial clearance of lesions

reaction, although rare in Type 2 reaction. However, the neural damage in Type 2 reaction requires several reactive episodes as the pathomechanism involving the damage in Type 2 reaction is a conduction block due to acute oedema, whereas the damage in Type 1 reaction is due to chronic demyelination. In our case, acute foot drop seen in patient had a temporal association with vaccine as it was seen few days after the second dose of Covid-19 vaccine. Neurological complications following Covid-19 vaccination has been documented in recent literature which is mentioned in Table 1. In this current Covid-19 pandemic and with global vaccination drive going on worldwide, it is critically important for clinicians to timely diagnose any neurological complications and other side-effects related to Covid-19 vaccination as there are very few literature suggesting the same. The trigger of Type 2 Lepra reaction should also be kept in mind in such patients presenting with acute manifestations following Covid-19 vaccination. Large real world clinical studies can help to establish this association.

[1]  R. Tomb,et al.  Eosinophilic panniculitis: a new side effect of Sinopharm COVID‐19 vaccine , 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  G. Argenziano,et al.  Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID‐19 vaccine: another piece of SARS‐CoV‐2 skin puzzle? , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  M. Cutrone,et al.  BNT162b2 mRNA COVID‐19 vaccine‐induced chilblain‐like lesions reinforces the hypothesis of their relationship with SARS‐CoV‐2 , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  M. Cutrone,et al.  Chilblain‐like lesions and COVID‐19: second wave, second outbreak , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  T. Russo,et al.  Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art , 2021, Life.

[6]  R. Jindal,et al.  Intralesional measles, mumps, and rubella vaccine immunotherapy in molluscum contagiosum: A retrospective observational study from a tertiary care center in north India , 2020, Dermatologic therapy.

[7]  T. Russo,et al.  Abnormal cutaneous reaction to potassium hydroxide in molluscum contagiosum in children: an observational study on 8 patients. , 2020, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[8]  V. Piccolo,et al.  Chilblain‐like lesions during the COVID‐19 pandemic: should we really worry? , 2020, International journal of dermatology.

[9]  V. Piccolo Update on Dermoscopy and Infectious Skin Diseases. , 2019, Dermatology practical & conceptual.

[10]  E. Siegfried,et al.  Molluscum BOTE Sign: A Predictor of Imminent Resolution , 2013, Pediatrics.

[11]  Megan S. Evans,et al.  Intralesional Immunotherapy with Candida Antigen for the Treatment of Molluscum Contagiosum in Children , 2011, Pediatric dermatology.